Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Effects of Powered Hip Flexion Device in Persons With Multiple Sclerosis

NCT07724093 · University of Dayton · Updated 23 July 2026

What is being tested
Powered Hip Flexion Orthosis (Hypershell X)
For
Multiple Sclerosis (MS) Relapsing Remitting
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 10 people. The full rules are on the registry page.
Where
United States
When
Starts or started 15 July 2026, ends 1 May 2028. Registered 23 July 2026.
Results
None posted yet.

In the researchers' words

The purpose of this study is to assess the immediate effects of a commercially available non-FDA regulated powered hip flexion assist device (Hypershell X, Shenzhen, China) on walking ability in persons with MS. The main question it aims to answer is: Does a powered hip flexion device provide immediate improvements in walking ability over short distances for people with MS?
ClinicalTrials.gov, NCT07724093

Sites

  • University of DaytonDayton, Ohio, United States